ULURU, Inc. (ULURU), a drug delivery and wound care devices company, has appointed Jeffrey Niezgoda to serve as chairman of the company's scientific advisory board. Presently, Jeffrey Niezgoda is the medical director of The Centers for Comprehensive Wound Care and Hyperbaric Oxygen Therapy, St. Luke's Medical Center, Aurora Health Care, in Milwaukee, Wisconsin.
Jeffrey Niezgoda also serves as the president and chief operating officer of Hyperbaric & Wound Care Associates and as the president of the American College of Hyperbaric Medicine.
Renaat Van den Hooff, president & chief executive officer of ULURU commented, “We are delighted that Dr. Niezgoda has accepted this important role with the Company. His extensive experience with Altrazeal(TM) has been invaluable and as Chairman of the Scientific Advisory Board, Dr. Niezgoda will help us to accelerate our clinical development and Altrazeal(TM) product development program.”
Jeffrey A. Niezgoda stated, “I continue to be impressed with the positive clinical results achieved using Altrazeal(TM). This product offers the potential to significantly change the way healthcare providers approach the treatment of wounds and I am pleased to have the opportunity to contribute to accomplish that vision.”